Literature DB >> 15954090

Viral and host factors in early hepatitis C virus infection.

James W Mosley1, Eva A Operskalski, Leslie H Tobler, William W Andrews, Bruce Phelps, Janel Dockter, Cristina Giachetti, Michael P Busch.   

Abstract

Since 1980, the Transfusion-transmitted Viruses Study (TTVS) (1974-1980) has continued to maintain its computerized database and stored sera to enable ongoing study of new transfusion events since the 1970s. Most recently, we have used this resource to study parameters of acute hepatitis C virus (HCV) infection among 94 donor-recipient pairs in which there was transmission. In addition, frequent recipient observations permitted further characterization of the early phase of the infection's course. Donor RNA load ranged from 3.7 to 3,160,000 IU/mL. Onset of recipient viremia was judged from a total of 67 sera collected during the 4th through 8th days posttransfusion; only 2 of the 67 sera were still RNA nonreactive by that time. The recipients' latent periods to an alanine aminotransferase (ALT) elevation of > or =90 IU/L ranged from 6 to 112 days (median, 46 days) and was shorter with higher donor RNA levels. Descriptors of the recipient's illness showed several strongly positive and negative correlations. The latent period tended to be shorter in the 37% of cases that were clinically overt. Attributes of donors with genotypes 1 and non-1 and subtypes 1a and 1b did not differ significantly. Recipients with genotype 1 strains had shorter latent intervals than non-1 strains. On multivariate analysis, latent period was significantly associated (negatively) only with the highest ALT level during the first 120 days of follow-up (P = .014). In conclusion, host factors are more important determinants of acute HCV infection dynamics than virus-associated factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954090     DOI: 10.1002/hep.20742

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME).

Authors:  Leslie H Tobler; Shrein H Bahrami; Zhanna Kaidarova; Lubov Pitina; Valarie K Winkelman; Sandra K Vanderpool; Anne M Guiltinan; Stewart Cooper; Michael P Busch; Edward L Murphy
Journal:  Transfusion       Date:  2010-03-25       Impact factor: 3.157

2.  Hepatitis C Virus Infection Caused by Infrequent Exposure in China Should Be of Concern.

Authors:  Xin-Cheng Qin; Li-Hua Zhong; Li-Ying Zhu; Alexander Plyusnin; Yong-Zhen Zhang
Journal:  Virol Sin       Date:  2020-02-21       Impact factor: 4.327

Review 3.  Global control of hepatitis C: where challenge meets opportunity.

Authors:  David L Thomas
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 4.  Transfusion transmission of HCV, a long but successful road map to safety.

Authors:  Suganya Selvarajah; Michael P Busch
Journal:  Antivir Ther       Date:  2012-12-07

5.  Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.

Authors:  Raouia ElFihry; Mohcine Elmessaoudi-Idrissi; Fatima-Zahra Jadid; Imane Zaidane; Hajar Chihab; Mohamed Tahiri; Mostafa Kabine; Wafaa Badre; Isabelle Chemin; Agnes Marchio; Pascal Pineau; Sayeh Ezzikouri; Soumaya Benjelloun
Journal:  Virol Sin       Date:  2020-04-15       Impact factor: 4.327

6.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

7.  Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.

Authors:  Kimberly Page-Shafer; Brandee L Pappalardo; Leslie H Tobler; Bruce H Phelps; Brian R Edlin; Andrew R Moss; Teresa L Wright; David J Wright; Thomas R O'Brien; Sally Caglioti; Michael P Busch
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

Review 8.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

Review 9.  Acute hepatitis C: management in the rapidly evolving world of HCV.

Authors:  Suraj A Sharma; Jordan J Feld
Journal:  Curr Gastroenterol Rep       Date:  2014-02

10.  Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection.

Authors:  S Deuffic-Burban; D Abiteboul; F Lot; M Branger; E Bouvet; Y Yazdanpanah
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.